MARKET

SUPN

SUPN

Supernus Pharma
NASDAQ
51.69
+2.34
+4.74%
Pre Market: 52.30 +0.61 +1.18% 08:40 04/01 EDT
OPEN
49.81
PREV CLOSE
49.35
HIGH
51.94
LOW
49.65
VOLUME
4.04K
TURNOVER
0
52 WEEK HIGH
59.68
52 WEEK LOW
29.16
MARKET CAP
2.98B
P/E (TTM)
-75.6919
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SUPN last week (0323-0327)?
Weekly Report · 2d ago
Supernus Pharmaceuticals (SUPN) Gets a Buy from Jefferies
TipRanks · 03/24 13:05
Weekly Report: what happened at SUPN last week (0316-0320)?
Weekly Report · 03/23 09:42
Supernus Sr. VP of IP and CSO Padmanabh P. Bhatt disposes of USD 5.4 million in common shares
Reuters · 03/18 21:19
Weekly Report: what happened at SUPN last week (0309-0313)?
Weekly Report · 03/16 09:42
Top Supernus Director Quietly Unloads a Major Chunk of Stock
TipRanks · 03/10 02:02
Weekly Report: what happened at SUPN last week (0302-0306)?
Weekly Report · 03/09 09:43
Supernus Pharmaceuticals Braces for 2025 U.S. Drug Pricing Orders and MFN Rules That Threaten Revenues and Global Expansion
TipRanks · 03/04 06:01
More
About SUPN
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company’s diverse neuroscience portfolio includes approved treatments for attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson’s disease (PD) patients receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea. It is also developing a range of product candidates for CNS disorders. Its commercial products that it markets include Qelbree, GOCOVRI, Oxtellar XR, Trokendi XR, APOKYN, XADAGO, MYOBLOC and ONAPGO. Its ONAPGO injection is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced PD. It also offers ZURZUVAE (zuranolone) capsules CIV, which is a U.S. FDA-approved oral medicine indicated for the treatment of adults with postpartum depression.

Webull offers Supernus Pharmaceuticals Inc stock information, including NASDAQ: SUPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SUPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SUPN stock methods without spending real money on the virtual paper trading platform.